Did you know that over 20 comorbidities have been linked to Atopic Dermatitis in 2018? Dr. Robert Sidbury from Seattle Children’s Hospital helped attendees of the SDPA Summer Conference sift through the published data related to atopic comorbidities. Dr. Sidbury relayed that it is an “incredibly dynamic” time in the field of atopy in both …
For the first product theater of the SDPA Annual Summer Conference, Cynthia Trickett, PA-C, reviewed Tremfya. Ms. Trickett specializes in the treatment of patients with psoriatic disease and discussed Tremfya as a first line therapy medication for patients 18 years or older with moderate to severe plaque psoriasis. As Ms. Trickett stated, “psoriasis affects and …
Dr. Rosen began Day 1 of the SDPA Annual Summer Conference this morning with a complementary message thanking PAs for being “the most open to adopting new technology and new drugs and pushing your doctors into the 21st century”. Dr. Rosen also vocalized his continued support of PAs! He started his review of the latest …
The SDPA Annual Summer Conference kicked off the morning pre-conference track with in an-depth look at dermoscopy. Dr. Jennie Clarke provided a quick overview of the history of dermoscopy while emphasizing that dermoscopy is not used for diagnosis but for guidance to determine the need to biopsy suspicious lesions. She highlighted that dermoscopy can be …
Atopic eczema is a common relapsing condition the affects up to 10% of adults. Because of its systemic inflammatory component, it is thought that atopic eczema may contribute to cardiovascular outcomes, but it is not known whether the cardiovascular risks may correlate with the severity of disease. A recent study explored whether adults with atopic …
Atopic dermatitis (AD) causes intense itching, and patients are often prescribed antihistamines to mitigate those effects. However, the evidence that non-sedating oral antihistamines are effective at controlling the itch is lacking. Sedating antihistamines have more studies that suggest they are useful. The American Academy of Dermatology (AAD) does not recommend the use of antihistamines for …